Speed Up Atopic Dermatitis Drug Development with Biocytogen’s Fully Human Antibody Innovations
February 14, 2025
Atopic Dermatitis (AD) is a chronic inflammatory skin condition characterized by intense itching, erythema, and scaly lesions, often leading to painful sores. It is also associated with comorbidities such as cardiovascular disease, mental health disorders (including depression and anxiety), and sleep disturbances. As of 2022, AD affects an estimated 320 million adults worldwide, with 30% […]
COPD in Focus: Current Challenges and New Horizons in Treatment with Biocytogen’s Antibody Innovation
January 13, 2025
Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory condition that affects millions of lives worldwide. Characterized by airflow obstruction caused by chronic bronchitis and/or emphysema, COPD manifests through symptoms such as shortness of breath, excessive mucus production, and coughing (Mayo Clinic, 2023). Its prevalence continues to rise due to aging populations, smoking, and worsening […]